Lv1
20 积分 2023-11-24 加入
Urticaria Beyond Omalizumab: What is Next?
30天前
已完结
The emerging role of Bruton’s tyrosine kinase inhibition in urticaria management
30天前
已完结
Ever-Increasing Role of Computational Tools in Solid-State Pharmaceutics: Advancing Drug Development with Enhanced Molecular Understanding and Risk Assessment
1个月前
已完结
Integrating artificial intelligence and physiologically based pharmacokinetic modeling to predict in vitro and in vivo fate of amorphous solid dispersions
1个月前
已完结
Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonist
1个月前
已完结
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
2个月前
已完结
Comparison of Pirfenidone and Nintedanib
2个月前
已完结
FDA approves new mechanism to treat idiopathic pulmonary fibrosis, expanding limited arsenal
2个月前
已完结
Nerandomilast, a PDE4B inhibitor, alleviates silica‐induced lung inflammation and fibrosis by inhibition of NLRP3 inflammasome and TGF‐β/Smad signalling
2个月前
已完结
Preparation, Characterization and Evaluation of Nintedanib Amorphous Solid Dispersions with Enhanced Oral Bioavailability
2个月前
已完结
皖公网安备34019202002308
